About UsMembershipMarketplaceResourcesGlobal Business Atlas
Top AI CompaniesTop Blockchain Influencers & AuthorsTop Global Digital AgenciesBusinessabc Country IndexesTop Accelerators and Chambers of CommerceTop Public Companies by MarketcapBusinessabc Education IndexesTop Malaysian Companies
DirectoryCompaniesLeadersInvestorsUniversitiesOrganisations
Loading wiki page…

Get Your Own Businessabc AI Visibility ID

Boost AI visibility, credibility, and discoverability

Learn More
Last Updated: 2026
Aurobindo Pharma image

Aurobindo Pharma

Rank#1994
Market Cap10.02B
CountryIndia
Summary
History
Mission
References
Summaryarrow
Aurobindo Pharma Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients, generic pharmaceuticals, and related services in India. The company primarily offers oral solids, injectables, and over-the-counter drugs, as well as active pharmaceutical ingredients and finished dosage forms for cardiovascular, central nervous system, gastroenterology, anti-allergies, anti-diabetics, anti-retroviral, antibiotics, dermatology, respiratory, and oncology. It is also involved in the development of a product pipeline in biosimilar and vaccine segments; and custom research and manufacturing activities for the bio-tech and pharmaceutical community. In addition, the company develops and manufactures peptides, as well as biocatalysts for use in the pharmaceutical and chemical industries. Further, it is developing biosimilar, inhalers, transdermal patches, vaccines, topicals, and depot injections. The company also exports its products. It serves multinational companies. The company has an agreement with COVAXX to develop and commercialize COVID-19 Vaccine for India and UNICEF. Aurobindo Pharma Limited was incorporated in 1986 and is headquartered in Hyderabad, India.
Historyarrow

Aurobindo Pharma was founded in 1986 by K Nityananda Reddy. He began by manufacturing a single acid compound, and slowly moved towards one of the first manufacturers of generic pharmaceuticals in India. Aurobindo was a pioneer in the industry, quickly expanding its products globally within a few years. In 1999, Aurobindo merged with Alembic, one of India’s oldest pharmaceutical companies.

Missionarrow
"To build a leading global generic pharma company and become one of the top 10 by 2020."
Referencesarrow

https://en.wikipedia.org/wiki/Aurobindo_Pharma

https://in.investing.com/equities/aurobindo-pharma

https://finance.yahoo.com/quote/AUROPHARMA.NS/profile?p=AUROPHARMA.NS

https://www.comparably.com/companies/aurobindo

https://www.crunchbase.com/organization/aurobindo-pharma

https://companiesmarketcap.com/

https://www.aurobindo.com

Share

Leadership team
M
Mr. Kambam Nithyananda Reddy (Vice Chairman & MD)
D
Dr. Meenakshi Sunderam Sivakumaran (Whole-Time Director)
M
Mr. Mettu Madan Mohan Reddy (Whole-Time Director)
Products / Services
Biotechnology, Pharmaceutical
Number of Employees
1,000 - 20,000
Address
Hyderabad, Andhra Pradesh, India
Established
1986-01-01
Net Income
S_100M_500M
Revenue
$1B+
Traded as
AUROPHARMA.NS
Website
https://www.aurobindo.com
Social Media
linkedinfacebook
Last Updated: 2026
Logo

Businessabc provides digital business directory, digital blockchain AI certification, resources, and marketplace for businesses, organisations, and professionals.

Contacts

Email
Contact

Follow Us

Created Produced

Partner logo
Partner logo

Tech AI Media Platforms

Partner logo
Partner logo
Partner logo
Partner logo
Partner logo
Partner logo

Copyright 2026 © Businessabc powered by

Powered by ztudium group

DisclaimerPrivacy PolicyTerms of Service
Partner logo
Partner logo
Partner logo
Partner logo
Partner logo
Partner logo